← Back to Clinical Trials
Recruiting NCT06455488

NCT06455488 MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06455488
Status Recruiting
Phase
Sponsor CorVita Science Foundation
Condition Ventricular Tachycardia
Study Type OBSERVATIONAL
Enrollment 130 participants
Start Date 2020-07-20
Primary Completion 2030-07-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Ventricular Tachycardia AblationICD ImplantAntiarrhythmic drug

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 130 participants in total. It began in 2020-07-20 with a primary completion date of 2030-07-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Eligibility Criteria

Inclusion Criteria: * Must be at least 18 years old * Must not be Exclusion Criteria: \-

Contact & Investigator

Central Contact

Martin C Burke, DO

✉ mburke@corvitahealth.org

📞 7735208322

Frequently Asked Questions

Who can join the NCT06455488 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Ventricular Tachycardia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06455488 currently recruiting?

Yes, NCT06455488 is actively recruiting participants. Contact the research team at mburke@corvitahealth.org for enrollment information.

Where is the NCT06455488 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT06455488 clinical trial?

NCT06455488 is sponsored by CorVita Science Foundation. The trial plans to enroll 130 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology